What Rx Communications does

Rx Communications Ltd is a UK-based medical communications (medcomms) agency founded in 2000, headquartered in Nercwys, Flintshire. The company specializes in health economics and outcomes research (HEOR) communications and positions itself as the longest-established and largest agency in this niche. It serves pharmaceutical, biotechnology, and medical device companies globally, with named enterprise clients including Takeda, Merck, Roche, AstraZeneca, and Pfizer.

The company's core offering is a portfolio of professional medical writing and publication support services, delivered through a network of specialized writers and project managers. Service lines include medical writing, scientific writing, regulatory writing (protocols, CSRs, NDAs/BLAs), clinical writing, medical education writing, HEOR writing (systematic literature reviews, cost-effectiveness analyses, real-world evidence studies, health technology assessments), publication support, congress support, and medical journal selection. The company operates across 15 therapeutic areas including oncology, cardiovascular, CNS, rare diseases, and metabolic conditions. Its Greenflint subsidiary provides adjacent health economics model development and communication strategy services. The company's proprietary framework is adherence to Good Publication Practice (GPP) guidelines, which functions as a compliance and credibility standard rather than a technology platform.

Rx Communications generates revenue through project-based professional services engagements, with custom quote-based pricing and multi-year contracts. No public pricing is disclosed. Distribution is direct enterprise sales—no resellers or marketplace channels—with the GTM motion centered on discovery consultations, tailored project scoping, and dedicated account management. The company supplements sales with content marketing through its 'Health Outcomes Communicator' newsletter and an active blog. Headcount is in the 11-50 range, and the company has delivered 2,706 publications, 1,088 custom projects, and 3,985 total projects cumulatively over its 25-year history. CEO Ruth Whittington leads the firm, which is privately held with no disclosed external investment or parent company.

Name

Rx Communications

Legal name

Rx Communications Ltd

Website

https://rxcomms.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Rx Communications is a UK-based medical communications agency specializing in health economics and outcomes research writing, publication support, and regulatory documentation for pharmaceutical, biotech, and medical device companies globally. Founded in 2000, it serves enterprise clients including Takeda, Merck, Roche, AstraZeneca, and Pfizer.

Ownership category

akta.pro rank

Product category

Medical Communications Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Communications Services, Nec (4899)

akta.pro primary industry

Medical Writing & Publications (Clinical/Safety/HEOR) (HLAGALAG)

akta.pro secondary industries

Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)

Keywords

• Medical communications services
• Medical writing services
• Health economics outcomes research
• Regulatory writing services
• Publication planning support

Headquarters

HQ city

Mold

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Writing Services: Project-based professional services for medical writing including manuscripts, abstracts, posters, and scientific documents. Services are tailored to individual client needs ranging from single deliverables to comprehensive communication plans.
2. HEOR Medical Writing Services: Specialized health economics and outcomes research writing including systematic literature reviews, cost-effectiveness analyses, real-world evidence studies, and health technology assessments to support market access and reimbursement strategies.
3. Regulatory Writing Services: Regulatory documentation services including clinical trial protocols, CSRs, NDAs, BLAs, and submission documents for regulatory approval processes.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Rx Communications is a medical communications agency that provides expert medical writing, publication planning, regulatory writing, HEOR communications, medical education, and congress support services to pharmaceutical, biotechnology, and medical device companies. Its deliverables include manuscripts, abstracts, posters, literature reviews, clinical study reports, regulatory submissions, and tailored communication plans, delivered by a global network of specialist writers and project managers under Good Publication Practice (GPP) guidelines.

Product overview

Rx Communications is a full-service medical communications (medcomms) agency offering a comprehensive portfolio of specialized writing and communications services. The core offerings include Medical Writing Services (encompassing Scientific, Regulatory, Clinical, Medical Education, and HEOR writing specialties), Publication Support, Congress Support, HEOR Solutions, and Big Pharma Solutions. These services are delivered through a network of experienced writers and project managers, supported by therapeutic area expertise. The company provides end-to-end capabilities from manuscript writing and literature reviews to journal selection, poster abstracts, and customized project delivery, all grounded in Good Publication Practice (GPP) guidelines and ethical standards.

Differentiator

Problem solved

Functional benefit

Brands

• Greenflint: Health economics expert team offering model development, project management, and communication strategies

Products and services

• Medical Writing Services Expert medical writing solutions spanning therapeutic areas, transforming complex scientific concepts into clear, compelling content for publications and communications; serves pharmaceutical, biotech, and medical device teams needing specialist writing support.
• Scientific Medical Writing Services Premier scientific writing services designed to articulate complex scientific data and findings through high-quality manuscripts, abstracts, posters, and more; serves pharmaceutical and biotech research teams.
• Regulatory Medical Writing Services Precision-driven regulatory writing services covering clinical trial protocols, CSRs, NDAs, BLAs, and submission documents tailored to meet stringent regulatory standards; serves pharma and biotech regulatory affairs teams.
• Clinical Medical Writing Services Expert preclinical and clinical writing services covering mechanism of action, pharmacodynamics, pharmacokinetics, and a wide variety of clinical topics and document types; serves pharmaceutical clinical development teams.
• Medical Education Writing Services Comprehensive medical education services designed to inform and empower healthcare professionals and patients, ensuring improved outcomes and enhanced knowledge dissemination; serves pharma medical affairs and medical education leads.
• HEOR Medical Writing Services Specialized medical writing support for systematic literature reviews, cost-effectiveness analyses, real-world evidence studies, and health technology assessments to support market access and reimbursement strategies; serves pharma and biotech market access teams.
• Publication Support Full suite of services to bring research to the world, covering the complete publication journey from manuscript development through journal submission; serves pharmaceutical and biotech publication leads.
• Congress Support Comprehensive congress support services spanning planning, speaker training, poster and abstract creation, and manuscript development for medical conferences; serves pharmaceutical and biotech medical affairs teams.
• HEOR Solutions Specialist solutions communicating health economics value to stakeholders through health economics and outcomes research communications, supporting market access and payer engagement; serves pharma and biotech market access teams.
• Big Pharma Solutions Tailored services aligned to the unique needs of large pharmaceutical companies, packaged as a dedicated solution for complex enterprise programs; serves large pharma medical affairs and publication leadership.
• MedComms Project Management End-to-end project management support through every stage of the publication journey, with expert coordination and timely execution of medical communications deliverables; serves pharma and biotech publication teams.
• Medical Manuscripts Professional manuscript writing and editing services for scientific publications; serves pharmaceutical and biotech authors needing dedicated manuscript support.
• Medical Journal Selection Expert journal selection, submission guidance, and rejection-handling support for optimal publication placement; serves pharmaceutical and biotech publication teams.
• Literature Reviews Comprehensive literature review services covering search strategy design, data synthesis, and full literature review delivery; serves pharma and biotech HEOR and medical affairs teams.
• Medical Poster Abstracts Congress poster and abstract creation services transforming data into compelling visual presentations; serves pharma and biotech conference presenters.
• Customised Projects Customised medcomms projects tailored to unique client needs across the medical communications spectrum, ranging from single deliverables to comprehensive communication plans; serves pharma, biotech, and medical device clients.

Quantifiable outcome

• 2706 publications successfully completed
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks1 record

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/rx-communications-ltd.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rx Communications